Argenx SE(ARGX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ARGX Argenx SE

休市中 07-17 16:00:00 EDT

860.55

+2.58

+0.30%

盘后860.55

+0.000.00%

17:00 EDT

最高862.55	最低843.59	成交量27.77万
今开847.66	昨收857.97	日振幅2.21%
总市值532.54亿	流通市值532.54亿	总股本6,188万
成交额2.38亿	换手率0.45%	流通股本6,188万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ARGX","market":"US","secType":"STK","nameCN":"Argenx SE","latestPrice":860.55,"timestamp":1784318400000,"preClose":857.97,"halted":0,"volume":277703,"hourTrading":{"tag":"盘后","latestPrice":860.55,"preClose":860.55,"latestTime":"17:00 EDT","volume":4735,"amount":4074715.85,"timestamp":1784322030330,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.00300709815028489,"floatShares":61883400,"shares":61883400,"eps":22.49267,"marketStatus":"休市中","change":2.58,"latestTime":"07-17 16:00:00 EDT","open":847.66,"high":862.55,"low":843.585,"amount":237837068.132,"amplitude":0.022105,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":22.49267,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1784534400000},"marketStatusCode":7,"adr":1,"adrRate":1,"listingDate":1495080000000,"exchange":"NASDAQ","adjPreClose":857.97,"preHourTrading":{"tag":"盘前","latestPrice":848.28,"preClose":857.97,"latestTime":"09:29 EDT","volume":1079,"amount":911576.4578699999,"timestamp":1784294997054,"change":-9.69,"changeRate":-0.011294,"amplitude":0.020793},"postHourTrading":{"tag":"盘后","latestPrice":860.55,"preClose":860.55,"latestTime":"17:00 EDT","volume":4735,"amount":4074715.85,"timestamp":1784322030330,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.02244193401219,"impliedVol":0.4037,"impliedVolPercentile":0.7331},"requestUrl":"/m/hq/s/ARGX","defaultTab":"news","newsList":[{"id":"1138281652","title":"财报前瞻｜Argenx SE本季度营收预计增53.14%，机构观点看多","url":"https://stock-news.laohu8.com/highlight/detail?id=1138281652","media":"财报Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138281652?lang=zh_cn&edition=full","pubTime":"2026-07-16 08:41","pubTimestamp":1784162472,"startTime":"0","endTime":"0","summary":"Argenx SE将于2026年07月23日美股盘前发布最新季度财报，市场关注核心产品放量与扩适应证后的处方转化节奏。一致预期显示，本季度Argenx SE营收预计为14.43亿美元，同比增长53.14%；调整后每股收益预计6.15美元，同比增长81.68%；同时，息税前利润预计4.35亿美元，同比增长131.46%，当前一致预期未见对本季度毛利率和净利润或净利率的明确披露，故不展示相关预测信息。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Argenx SE本季度营收预计增53.14%，机构观点看多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122187562","title":"异动解读｜Argenx SE盘中下跌3.66%，报876.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1122187562","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122187562?lang=zh_cn&edition=full","pubTime":"2026-07-11 00:13","pubTimestamp":1783700024,"startTime":"0","endTime":"0","summary":"7月11日，Argenx SE盘中下跌3.66%，报876.24美元/股，成交额1.78亿美元。Argenx SE所在的生物科技行业中，整体表现疲弱，个股中，艾伯维公司跌1.35%，Ionis Pharmaceuticals跌8.74%，Moderna跌10.51%，吉利德科学跌3.24%，阿尔尼拉姆制药公司跌4.30%。Argenx SE是一家处于商业阶段的全球性生物制药公司，核心产品Vyvgart用于治疗严重自身免疫性疾病，公司下次财报将于7月23日盘前发布。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166643955","title":"异动解读｜Argenx SE盘中上涨3.02%，报935.745美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1166643955","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166643955?lang=zh_cn&edition=full","pubTime":"2026-07-02 22:06","pubTimestamp":1783001192,"startTime":"0","endTime":"0","summary":"7月2日，Argenx SE盘中上涨3.02%，报935.745美元/股，成交额4630.24万美元。Argenx SE所在的生物科技行业中，整体表现偏强，个股中，Moderna涨10.69%，Abivax S.A.涨8.97%，艾伯维公司涨1.43%，福泰制药涨3.21%，Propanc Biopharma涨42.36%。Argenx SE是一家处于商业阶段的全球性生物制药公司，核心产品Vyvgart用于治疗严重自身免疫性疾病，目前已获批用于全血清型广泛性重症肌无力及慢性炎症性脱髓鞘多神经病变等适应症。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127918059","title":"异动解读｜Argenx SE盘中下跌3.05%，报899.435美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1127918059","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127918059?lang=zh_cn&edition=full","pubTime":"2026-07-02 00:51","pubTimestamp":1782924700,"startTime":"0","endTime":"0","summary":"7月1日，Argenx SE盘中下跌3.05%，报899.435美元/股，成交额2.0亿美元。Argenx SE所在的生物科技行业中，整体表现分化，个股中，艾伯维公司跌0.6%，Abivax S.A.涨0.74%，安进跌0.63%，Can-Fite Biopharma涨42.63%，吉利德科学跌0.16%。Argenx SE是一家处于商业阶段的全球性生物制药公司，核心产品Vyvgart用于治疗严重自身免疫性疾病，目前已获批用于全血清型广泛性重症肌无力及慢性炎症性脱髓鞘多神经病变等适应症。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123056084","title":"异动解读｜Argenx SE盘中上涨4.21%，法国巴黎银行给予跑赢大盘评级","url":"https://stock-news.laohu8.com/highlight/detail?id=1123056084","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123056084?lang=zh_cn&edition=full","pubTime":"2026-06-26 00:15","pubTimestamp":1782404105,"startTime":"0","endTime":"0","summary":"6月25日，Argenx SE盘中上涨4.21%，报887.71美元/股，成交额2.36亿美元。消息面上，法国巴黎银行近日首次覆盖Argenx，给予\"跑赢大盘\"评级，目标价1,219美元，较当前股价隐含约37%的上行空间，明显高于市场共识目标价1,064.53美元，对市场情绪形成持续提振。此外，公司核心产品Vyvgart已于今年5月获FDA批准扩展至全血清型重症肌无力患者，叠加一季度EPS 5.52美元超预期，基本面支撑推动股价延续涨势。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159712045","title":"异动解读｜Argenx SE盘前上涨3.55%，法国巴黎银行给予跑赢大盘评级","url":"https://stock-news.laohu8.com/highlight/detail?id=1159712045","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159712045?lang=zh_cn&edition=full","pubTime":"2026-06-24 16:07","pubTimestamp":1782288430,"startTime":"0","endTime":"0","summary":"6月24日，Argenx SE盘前上涨3.55%，报868.83美元/股，成交额2.03万美元。消息面上，法国巴黎银行近日将Argenx评级为\"跑赢大盘\"，并给出1,219美元的目标价，较当前股价隐含约40%的上行空间。据FactSet数据，该股分析师平均评级为\"买入\"，平均目标价为1,064.53美元。法国巴黎银行的目标价明显高于市场共识，对市场情绪形成积极提振，推动股价延续近日涨势。Argenx SE是一家处于商业阶段的全球性生物制药公司，专注开发用于治疗严重自身免疫性疾病的差异化疗法。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178462515","title":"异动解读｜Argenx SE夜盘上涨5.46%，法国巴黎银行给予跑赢大盘评级","url":"https://stock-news.laohu8.com/highlight/detail?id=1178462515","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178462515?lang=zh_cn&edition=full","pubTime":"2026-06-24 15:02","pubTimestamp":1782284520,"startTime":"0","endTime":"0","summary":"6月24日，Argenx SE夜盘上涨5.46%，报900.0美元/股，成交额5.13万美元。消息面上，法国巴黎银行近日将Argenx评级为\"跑赢大盘\"，并给出1,219美元的目标价，较当前股价隐含较大上行空间。据FactSet数据，该股分析师平均评级为\"买入\"，平均目标价为1,064.53美元。法国巴黎银行的目标价明显高于市场共识，对市场情绪形成积极提振，推动股价延续近日涨势。Argenx SE是一家处于商业阶段的全球性生物制药公司，专注开发用于治疗严重自身免疫性疾病的差异化疗法。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195743704","title":"异动解读｜Argenx SE盘中上涨3.08%，法国巴黎银行给予跑赢大盘评级","url":"https://stock-news.laohu8.com/highlight/detail?id=1195743704","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195743704?lang=zh_cn&edition=full","pubTime":"2026-06-24 00:39","pubTimestamp":1782232759,"startTime":"0","endTime":"0","summary":"6月23日，Argenx SE盘中上涨3.08%，报931.58美元/股，成交额1.34亿美元。消息面上，法国巴黎银行近日将Argenx评级为\"跑赢大盘\"，并给出1,219美元的目标价，较当前股价隐含约31%的上行空间。据FactSet数据，该股分析师平均评级为\"买入\"，平均目标价为1,064.53美元。法国巴黎银行的目标价明显高于市场共识，对市场情绪形成积极提振。Argenx SE是一家处于商业阶段的全球性生物制药公司，专注开发用于治疗严重自身免疫性疾病的差异化疗法。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197954784","title":"异动解读｜Argenx SE盘中上涨3.71%，法国巴黎银行给予跑赢大盘评级","url":"https://stock-news.laohu8.com/highlight/detail?id=1197954784","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197954784?lang=zh_cn&edition=full","pubTime":"2026-06-23 00:13","pubTimestamp":1782144810,"startTime":"0","endTime":"0","summary":"6月23日，Argenx SE盘中上涨3.71%，报910.27美元/股，成交额1.9亿美元。消息面上，法国巴黎银行近日将argenx评级为\"跑赢大盘\"，并给出1,219美元的目标价，较当前股价隐含约34%的上行空间。据FactSet数据，该股分析师平均评级为\"买入\"，平均目标价为1,064.53美元。法国巴黎银行的目标价明显高于市场共识，对市场情绪形成积极提振。Argenx SE是一家处于商业阶段的全球性生物制药公司，专注开发用于治疗严重自身免疫性疾病的差异化疗法。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107841283","title":"异动解读｜Argenx SE盘中上涨6.11%，报894.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1107841283","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107841283?lang=zh_cn&edition=full","pubTime":"2026-06-06 00:15","pubTimestamp":1780676152,"startTime":"0","endTime":"0","summary":"6月6日，Argenx SE盘中上涨6.11%，报894.36美元/股，成交额3.9亿美元。Argenx SE所在的生物科技行业中，个股中，BioCardia涨34.34%，安进涨2.54%，艾伯维公司涨1.92%，福泰制药涨1.46%，吉利德科学涨1.11%。Argenx SE是一家处于商业阶段的全球性生物制药公司，专注于开发用于治疗严重自身免疫性疾病的差异化疗法，公司于2008年在荷兰成立，2014年转为上市有限责任公司。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170531813","title":"财报前瞻｜Argenx SE本季度营收预计增65.79%，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1170531813","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170531813?lang=zh_cn&edition=full","pubTime":"2026-04-30 10:10","pubTimestamp":1777515039,"startTime":"0","endTime":"0","summary":"Argenx SE将于2026年05月07日盘前发布季度财报，市场聚焦Vyvgart放量与利润弹性。市场一致预期本季度Argenx SE营收为13.19亿美元，同比增长65.79%；调整后每股收益为5.38美元，同比增长134.87%；EBIT为4.08亿美元，同比增长230.92%，一致预期暂未提供毛利率与净利润或净利率的具体预测，公司上季度披露材料中未见针对本季度的明确营收指引。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Argenx SE本季度营收预计增65.79%，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146795629","title":"财报前瞻｜Argenx SE本季度营收预计增82.85%，市场观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1146795629","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146795629?lang=zh_cn&edition=full","pubTime":"2026-02-19 10:15","pubTimestamp":1771467344,"startTime":"0","endTime":"0","summary":"Argenx SE将于2026年02月26日发布最新季度财报，市场关注Vyvgart适应症拓展与盈利延续为核心主线。市场一致预期本季度Argenx SE营收为12.91亿美元，同比增加82.85%；调整后每股收益为5.73美元，同比增加33.57%。公司未披露本季度毛利率与净利率的量化预测。上季度Argenx SE营收11.51亿美元，同比增长95.51%；毛利率59.61%；归属母公司净利润3.44亿美元；净利率29.90%；调整后每股收益5.18美元，同比增长272.66%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Argenx SE本季度营收预计增82.85%，市场观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606079121","title":"Argenx Se盘中异动 早盘股价大涨5.06%报875.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606079121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606079121?lang=zh_cn&edition=full","pubTime":"2026-01-27 23:40","pubTimestamp":1769528443,"startTime":"0","endTime":"0","summary":"北京时间2026年01月27日23时40分，Argenx Se股票出现异动，股价大幅上涨5.06%。截至发稿，该股报875.32美元/股，成交量16.7804万股，换手率0.27%，振幅3.47%。Argenx Se股票所在的生物技术行业中，整体涨幅为1.47%。2022年，Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准，与Vyvgart的静脉给药相比，这是一种更方便的选择。2024年，FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变，这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127234043a6b3af2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127234043a6b3af2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARGX","BK4505","IE0034235188.USD","BK4588","LU1983260115.SGD","LU2324357040.USD","LU0109394709.USD","BK4585","IE00B4R5TH58.HKD","IE0002141913.USD","LU0320765992.SGD","LU0889565916.HKD","IE00BJT1NW94.SGD","BK4139","IE00B2B36J28.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516390377","title":"富国银行：维持argenx(ARGX.US)评级，由增持调整至增持评级, 目标价由723.00美元调整至741.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516390377","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516390377?lang=zh_cn&edition=full","pubTime":"2025-03-01 01:31","pubTimestamp":1740763885,"startTime":"0","endTime":"0","summary":"富国银行：维持argenx(ARGX.US)评级，由增持调整至增持评级, 目标价由723.00美元调整至741.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/01013148469987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514337690","title":"Citizens Capital Markets：维持argenx(ARGX.US)评级，由优于大市调整至优于大市评级, 目标价由696.00美元调整至701.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514337690","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514337690?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:41","pubTimestamp":1740757319,"startTime":"0","endTime":"0","summary":"Citizens Capital Markets：维持argenx(ARGX.US)评级，由优于大市调整至优于大市评级, 目标价由696.00美元调整至701.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28234148468149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142674592","title":"argenx 2024年第四季度GAAP每股收益$11.79，同比增长至$(1.68)；销售额$7.6122亿，高于$7.0628亿预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1142674592","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142674592?lang=zh_cn&edition=full","pubTime":"2025-02-27 14:22","pubTimestamp":1740637328,"startTime":"0","endTime":"0","summary":"argenx公布季度每股收益为$11.79。公司季度销售额为$7.6122亿，超过分析师一致预期的$7.0628亿，超出7.78%。与去年同期$4.1784亿销售额相比，同比增长了82.18%。以上内容来自Benzinga Earnings专栏，原文如下：argenx  reported quarterly earnings of $11.79 per share. This is a 801.79 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $761.22 million which beat the analyst consensus estimate of $706.28 million by 7.78 percent.  This is a 82.18 percent increase over sales of $417.84 million the same period last ye","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"argenx 2024年第四季度GAAP每股收益$11.79，同比增长至$(1.68)；销售额$7.6122亿，高于$7.0628亿预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504449484","title":"特朗普2.0时代即将开启，投资机会如何掘金？","url":"https://stock-news.laohu8.com/highlight/detail?id=2504449484","media":"招商基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504449484?lang=zh_cn&edition=full","pubTime":"2025-01-20 10:36","pubTimestamp":1737340585,"startTime":"0","endTime":"0","summary":"美国候任总统唐纳德·特朗普将于美东时间1月20日12时正式宣誓就任美国第47任总统。特朗普2.0时代即将开启，有哪些投资机会可以布局？值得一提的是，科技股在特朗普任期内表现尤为突出，成为推动美股上涨的主要力量。在特朗普第一个任期内，美元整体表现相对弱势。4年任期内，美元指数累计下跌了10.53%。而纵观全球市场，在特朗普上一任期内，恒生科技指数涨幅超过147%，表现甚至略微优于纳斯达克指数。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120103318abb12e8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120103318abb12e8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RYAAY","SBAC","STLD","RPRX","BK4588","CDNS","QQQ","CHRD","TTWO","EBAY","BK4585","KHC","AFRM","AVGO","LI","GEN","AKAM","MNQmain","HON","FYBR","PDD","MCHP","DOCU","CSGP","LOGI","PNFP","DDOG","CINF","LECO","FAST","TW","EQIX","FSV","NVMI","LSCC","ANSS","USAW.SI","LU1815336091.USD","PSQ","GLPI","REGN","CPRT","APA","FWONK","TSEM","ILMN","NQmain","SQQQ","MRVL","SSNC","CEG","MANH","FOX","SFM","SMCI","ENPH","SEIC","WWD","AGNC","NTRA","ON","TTD","PCVX","AMD","NICE","SNPS","ONC","TTEK","CBSH","PAYX","ERIC","ZM","DPZ","LKQ","GNTX","FCNCA","ASML","POOL","LNT","MDB","IDXX","BKR","MTCH","BK4086","CHKP","COIN","DSGX","ESLT","ICLR","AMAT","NDSN","NTRS","TECH","AXON","CHTR","JD","BK4550","AAPL","CWST","TMUS","CG","MKSI","ROIV","NFLX","QID","REG","MIDD","PFG","MELI","DOX","QXO","TROW","EXAS","AAL","MNDY","BIIB","LU2065731478.USD","CSWI","BKNG","FOXA","AMZN",".IXIC","CHDN","FFIV","PTC","RADX","SBUX","AEP","PLTR","ALGN","LPLA","HBAN","CYBR","ADSK","COO","ISRG","TLN","INSM","FTAI","GOOGL","RGEN","BK4581","NVDA","EVRG","SOFI","NTAP","TXN","GMAB","MDLZ","JKHY","KDP","EXE","NTNX","INTC","USJW.SI","MEDP","JBHT","GEHC","FER","MRNA","EA","COKE","DUOL","TCOM","GTLB","TEAM","NDAQ","SRPT","LU0757428866.USD","INTU","NVIW.SI","QLD","TER","FSLR","RGLD","ULTA","MMYT","NWSA","ROST","OTEX","NBIX","DLTR","WTFC","ALAB","QCOM","RVMD","TQQQ","CME","TPG","AAON","LSTR","ADBE","ERIE","BPMC","CPB","RKLB","SIRI","HSIC","TSLA","HLNE","BK4534","LIN","CFLT","ROP","ARM","CSX","ENTG","HOOD","LAMR","GRAB","LU0053671581.USD","LULU","MTSI","QRVO","CRWD","TSCO","Z","LNW","EXPE","AMGN","FTNT","HQY","CSCO","CTSH","ODFL","CASY","MKTX","PCTY","AZN","MSFT","PARA","COST","SAIA","PODD","AUR","OKTA","WBA","PAA","OLED","BPOP","DASH","ORLY","HTHT","STX","HST","BRKR","NXPI","ITCI","ADI","EWBC","MPWR","MNST","ROKU","CZR","SWKS","ZS","BK4561","FRPT","MARA","GILD","PCAR","PEP","NTES","TRMB","WDC","META","ARGX","CTAS","TSYW.SI","RIVN","BMRN","CDW","BSY","CHRW","INCY","ALNY","WYNN","CCEP","HOLX","BK4593","DKNG"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2503501033","title":"HC Wainwright & Co.：重申argenx(ARGX.US)评级，由买入调整至买入评级, 目标价由670.00美元调整至717.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2503501033","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503501033?lang=zh_cn&edition=full","pubTime":"2025-01-15 01:34","pubTimestamp":1736876047,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申argenx(ARGX.US)评级，由买入调整至买入评级, 目标价由670.00美元调整至717.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/15013447459172.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503570065","title":"Truist Securities：重申argenx(ARGX.US)评级，由买入调整至买入评级, 目标价由660.00美元调整至700.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2503570065","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503570065?lang=zh_cn&edition=full","pubTime":"2025-01-14 23:50","pubTimestamp":1736869851,"startTime":"0","endTime":"0","summary":"Truist Securities：重申argenx(ARGX.US)评级，由买入调整至买入评级, 目标价由660.00美元调整至700.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/14235047458887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501027552","title":"Piper Sandler：维持argenx(ARGX.US)评级，由增持调整至增持评级, 目标价由620.00美元调整至725.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2501027552","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501027552?lang=zh_cn&edition=full","pubTime":"2025-01-07 22:12","pubTimestamp":1736259157,"startTime":"0","endTime":"0","summary":"Piper Sandler：维持argenx(ARGX.US)评级，由增持调整至增持评级, 目标价由620.00美元调整至725.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/07221247232536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ARGX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.argenx.com","stockEarnings":[{"period":"1week","weight":-0.0195},{"period":"1month","weight":-0.0355},{"period":"3month","weight":0.0136},{"period":"6month","weight":0.0757},{"period":"1year","weight":0.5026},{"period":"ytd","weight":0.0233}],"compareEarnings":[{"period":"1week","weight":-0.0154},{"period":"1month","weight":0.0031},{"period":"3month","weight":0.0467},{"period":"6month","weight":0.0746},{"period":"1year","weight":0.1835},{"period":"ytd","weight":0.09}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Argenx Se根据荷兰法律于2008年4月25日成立，是一家私人有限责任公司（besloten vennootschap met beperkte aansprakelijkheid）。 于2014年5月28日，根据公证转换契约及修订，该公司转为上市有限责任公司（naamloze vennootschap）。 该公司是一家处于商业阶段的、全球性的、完全整合的生物制药公司，开发用于治疗严重自身免疫性疾病的差异化疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.007923},{"month":2,"riseRate":0.333333,"avgChangeRate":0.026997},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.02217},{"month":4,"riseRate":0.777778,"avgChangeRate":0.0372},{"month":5,"riseRate":0.555556,"avgChangeRate":0.061118},{"month":6,"riseRate":0.8,"avgChangeRate":0.059431},{"month":7,"riseRate":0.6,"avgChangeRate":0.070784},{"month":8,"riseRate":0.666667,"avgChangeRate":0.01751},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.022149},{"month":10,"riseRate":0.666667,"avgChangeRate":0.037064},{"month":11,"riseRate":0.777778,"avgChangeRate":0.116374},{"month":12,"riseRate":0.444444,"avgChangeRate":0.116024}],"exchange":"NASDAQ","name":"Argenx SE","nameEN":"Argenx SE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Argenx SE(ARGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Argenx SE(ARGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Argenx SE,ARGX,Argenx SE股票,Argenx SE股票老虎,Argenx SE股票老虎国际,Argenx SE行情,Argenx SE股票行情,Argenx SE股价,Argenx SE股市,Argenx SE股票价格,Argenx SE股票交易,Argenx SE股票购买,Argenx SE股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Argenx SE(ARGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Argenx SE(ARGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}